Start for free
Start for free
3×5 Partners logo

3×5 Partners

North America, Oregon, United States, Portland

Description

3×5 Partners is a venture capital firm that focuses on innovations in the life science and resource-driven sectors.

Investor Profile

3×5 Partners has made 16 investments, with 0 in the past 12 months and 44% as lead.

Stage Focus

  • Series B (31%)
  • Series A (31%)
  • Series C (25%)
  • Series D (6%)
  • Series E (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
  • Life Science
  • Therapeutics
  • Clinical Trials
  • Manufacturing
  • Enterprise Software
  • Marketplace
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 3×5 Partners frequently co-invest with?

Adage Capital Management
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
L
Co-Investments: 2
Codon Capital
Codon Capital
North America, California, United States, San Francisco
Co-Investments: 2
RiverVest
RiverVest
North America, Missouri, United States, St Louis
Co-Investments: 8
Digitalis Ventures
Digitalis Ventures
North America, New York, United States, New York
Co-Investments: 4
Alta Partners
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
Breakthrough Energy Ventures
Breakthrough Energy Ventures
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Roche Venture Fund
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
Rally Ventures
Rally Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

What are some of recent deals done by 3×5 Partners?

Kaleidoscope

Minneapolis, Minnesota, United States

Kaleidoscope designs, administers, and hosts branded scholarship and grant programs on a cloud-based marketplace.

Enterprise SoftwareMarketplacePredictive AnalyticsSocial EntrepreneurshipSoftware
Series AAug 8, 2023
Amount Raised: $2,000,000
Bonum Therapeutics

Seattle, Washington, United States

Bonum Therapeutics creates a technology platform to treat a wide range of diseases.

BiotechnologyLife ScienceMedicalTherapeutics
Series ANov 15, 2022
Amount Raised: $93,000,000
Fervo Energy

Houston, Texas, United States

Fervo Energy develops clean energy technology to generate carbon-free energy from geothermal systems.

NuclearPlastics and Rubber Manufacturing
Series CAug 22, 2022
Amount Raised: $138,000,000
Kaleidoscope

Minneapolis, Minnesota, United States

Kaleidoscope designs, administers, and hosts branded scholarship and grant programs on a cloud-based marketplace.

Enterprise SoftwareMarketplacePredictive AnalyticsSocial EntrepreneurshipSoftware
Series AApr 4, 2022
Amount Raised: $10,000,000
Koya Medical

Oakland, California, United States

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

BiotechnologyHealth CareInternetPharmaceutical
Series BFeb 3, 2022
Amount Raised: $26,000,000
Good Therapeutics

Seattle, Washington, United States

Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.

BiotechnologyLife SciencePharmaceutical
Series BDec 30, 2021
Amount Raised: $8,000,000
Arch Oncology

St Louis, Missouri, United States

Arch Oncology is a venture-stage biopharmaceutical company.

BiotechnologyMedicalOncologyTherapeutics
Series CApr 27, 2021
Amount Raised: $105,000,000
Source

Scottsdale, Arizona, United States

Source is a developer and manufacturer of solar-powered devices designed to extract drinkable water from the atmosphere.

Environmental EngineeringManufacturingRenewable EnergyWaterWater Purification
Series CJun 17, 2020
Amount Raised: $50,000,000
Amplyx Pharmaceuticals

San Diego, California, United States

Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems

BiotechnologyClinical TrialsMedicalPharmaceutical
Series CMay 19, 2020
Amount Raised: $53,000,000
Good Therapeutics

Seattle, Washington, United States

Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.

BiotechnologyLife SciencePharmaceutical
Series AMay 7, 2020
Amount Raised: $11,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator